Skip to main content
Top
Published in: Supportive Care in Cancer 11/2012

01-11-2012 | Original Article

Analysis of ECOG performance status in head and neck squamous cell carcinoma patients: association with sociodemographical and clinical factors, and overall survival

Authors: Gefter Thiago Batista Corrêa, Gabriela Alencar Bandeira, Bruna Gonçalves Cavalcanti, Francis Balduíno Guimarães Santos, João Felício Rodrigues Neto, André Luiz Sena Guimarães, Desirée Sant’Ana Haikal, Alfredo Maurício Batista De Paula

Published in: Supportive Care in Cancer | Issue 11/2012

Login to get access

Abstract

Purpose

In the present study, we analyzed sociodemographical and clinical factors, and the Eastern Cooperative Oncology Group performance status (ECOG-PS) scale in head and neck squamous cell carcinoma (HNSCC) patients. We evaluated the impact of a range of variables on overall survival.

Methods

We investigated a sample of HNSCC patients (n = 671), using sociodemographical and clinical information, and survival data collected from a review of epidemiological, clinical, and treatment reports. Statistical associations were analyzed by bivariate and multivariate statistical tests. Statistical significance was set at p < 0.05.

Results

Of patients 85.4% recorded good ECOG-PS scores. Poor ECOG-PS scores were associated with the covariates indicative of dysphagia [odd ratios (OR) = 2.660, CI 95% = 1.661–4.260, p = 0.000] and large-size malignant disease (T3–T4; OR = 5.337, CI 95% = 2.251–12.652, p = 0.000). Overall survival analysis revealed that ECOG-PS scores (OR = 1.879, CI 95% = 1.162–3.038, p = 0.010), tumor size (OR = 1.665, CI 95% = 1.035–2.680, p = 0.036), and the presence of cervical metastasis (OR = 3.145, CI 95% = 2.008–4.926, p = 0.000) were independent predictors.

Conclusion

Evaluation of physical consumption in head and neck cancer patients at diagnosis may indicate a more aggressive type of malignant disease. Thus, the ECOG-PS scale may help to identify HNSCC patients in need of rapid referral, who may benefit from specific therapeutic and rehabilitative interventions.
Literature
1.
3.
go back to reference Warnakulasuriya S (2009) Global epidemiology of oral and oropharyngeal cancer. Oral Oncol 45:309–316PubMedCrossRef Warnakulasuriya S (2009) Global epidemiology of oral and oropharyngeal cancer. Oral Oncol 45:309–316PubMedCrossRef
4.
go back to reference Warnakulasuriya S (2009) Significant oral cancer risk associated with low socioeconomic status. Evid Based Dent 10:4–5PubMedCrossRef Warnakulasuriya S (2009) Significant oral cancer risk associated with low socioeconomic status. Evid Based Dent 10:4–5PubMedCrossRef
5.
go back to reference Argiris A, Eng C (2003) Epidemiology, staging, and screening of head and neck cancer. Cancer Treat Res 114:15–60PubMedCrossRef Argiris A, Eng C (2003) Epidemiology, staging, and screening of head and neck cancer. Cancer Treat Res 114:15–60PubMedCrossRef
6.
go back to reference Correa GT, Bandeira GA, Cavalcanti BG, de Carvalho Fraga CA, dos Santos EP, Silva TF, Gomez RS, Guimaraes AL, De Paula AM (2011) Association of -308 TNF-alpha promoter polymorphism with clinical aggressiveness in patients with head and neck squamous cell carcinoma. Oral Oncol 47:888–894PubMedCrossRef Correa GT, Bandeira GA, Cavalcanti BG, de Carvalho Fraga CA, dos Santos EP, Silva TF, Gomez RS, Guimaraes AL, De Paula AM (2011) Association of -308 TNF-alpha promoter polymorphism with clinical aggressiveness in patients with head and neck squamous cell carcinoma. Oral Oncol 47:888–894PubMedCrossRef
7.
go back to reference Moore SR, Johnson NW, Pierce AM, Wilson DF (2000) The epidemiology of mouth cancer: a review of global incidence. Oral Dis 6:65–74PubMedCrossRef Moore SR, Johnson NW, Pierce AM, Wilson DF (2000) The epidemiology of mouth cancer: a review of global incidence. Oral Dis 6:65–74PubMedCrossRef
8.
go back to reference Ries JC, Hassfurther E, Steininger H, Kloss FR, Wiltfang J, Girod SC, Neukam FW (2001) Correlation of telomerase activity, clinical prognosis and therapy in oral carcinogenesis. Anticancer Res 21:1057–1063PubMed Ries JC, Hassfurther E, Steininger H, Kloss FR, Wiltfang J, Girod SC, Neukam FW (2001) Correlation of telomerase activity, clinical prognosis and therapy in oral carcinogenesis. Anticancer Res 21:1057–1063PubMed
9.
go back to reference Silverman S Jr (2001) Demographics and occurrence of oral and pharyngeal cancers. The outcomes, the trends, the challenge. J Am Dent Assoc 132 Suppl Silverman S Jr (2001) Demographics and occurrence of oral and pharyngeal cancers. The outcomes, the trends, the challenge. J Am Dent Assoc 132 Suppl
10.
go back to reference De Paula AM, Souza LR, Farias LC, Correa GT, Fraga CA, Eleuterio NB, Silveira AC, Santos FB, Haikal DS, Guimaraes AL, Gomez RS (2009) Analysis of 724 cases of primary head and neck squamous cell carcinoma (HNSCC) with a focus on young patients and p53 immunolocalization. Oral Oncol 45:777–782PubMedCrossRef De Paula AM, Souza LR, Farias LC, Correa GT, Fraga CA, Eleuterio NB, Silveira AC, Santos FB, Haikal DS, Guimaraes AL, Gomez RS (2009) Analysis of 724 cases of primary head and neck squamous cell carcinoma (HNSCC) with a focus on young patients and p53 immunolocalization. Oral Oncol 45:777–782PubMedCrossRef
11.
go back to reference van der Schroeff MP, Baatenburg de Jong RJ (2009) Staging and prognosis in head and neck cancer. Oral Oncol 45:356–360PubMedCrossRef van der Schroeff MP, Baatenburg de Jong RJ (2009) Staging and prognosis in head and neck cancer. Oral Oncol 45:356–360PubMedCrossRef
12.
go back to reference Vermorken P, Specenier JB (2010) Optimal treatment for recurrent/metastatic head and neck cancer. Ann Oncol 21(Suppl 7):vii252–vii261PubMedCrossRef Vermorken P, Specenier JB (2010) Optimal treatment for recurrent/metastatic head and neck cancer. Ann Oncol 21(Suppl 7):vii252–vii261PubMedCrossRef
13.
go back to reference Cooper JS, Porter K, Mallin K, Hoffman HT, Weber RS, Ang KK, Gay EG, Langer CJ (2009) National Cancer Database report on cancer of the head and neck: 10-year update. Head Neck 31:748–758PubMedCrossRef Cooper JS, Porter K, Mallin K, Hoffman HT, Weber RS, Ang KK, Gay EG, Langer CJ (2009) National Cancer Database report on cancer of the head and neck: 10-year update. Head Neck 31:748–758PubMedCrossRef
15.
go back to reference Shah JP, Gil Z (2009) Current concepts in management of oral cancer—surgery. Oral Oncol 45:394–401PubMedCrossRef Shah JP, Gil Z (2009) Current concepts in management of oral cancer—surgery. Oral Oncol 45:394–401PubMedCrossRef
16.
go back to reference Dewys WD, Begg C, Lavin PT, Band PR, Bennett JM, Bertino JR, Cohen MH, Douglass HO Jr, Engstrom PF, Ezdinli EZ, Horton J, Johnson GJ, Moertel CG, Oken MM, Perlia C, Rosenbaum C, Silverstein MN, Skeel RT, Sponzo RW, Tormey DC (1980) Prognostic effect of weight loss prior to chemotherapy in cancer patients. Eastern Cooperative Oncology Group. Am J Med 69:491–497PubMedCrossRef Dewys WD, Begg C, Lavin PT, Band PR, Bennett JM, Bertino JR, Cohen MH, Douglass HO Jr, Engstrom PF, Ezdinli EZ, Horton J, Johnson GJ, Moertel CG, Oken MM, Perlia C, Rosenbaum C, Silverstein MN, Skeel RT, Sponzo RW, Tormey DC (1980) Prognostic effect of weight loss prior to chemotherapy in cancer patients. Eastern Cooperative Oncology Group. Am J Med 69:491–497PubMedCrossRef
17.
go back to reference Glare P, Sinclair C, Downing M, Stone P, Maltoni M, Vigano A (2008) Predicting survival in patients with advanced disease. Eur J Cancer 44:1146–1156PubMedCrossRef Glare P, Sinclair C, Downing M, Stone P, Maltoni M, Vigano A (2008) Predicting survival in patients with advanced disease. Eur J Cancer 44:1146–1156PubMedCrossRef
18.
go back to reference Zubrod CG, Ipsen J, Frei E, Lasagna LC, Lipsett MB, Gehan E, Escher GC (1960) Newer techniques and some problems in cooperative group studies. Natl Cancer Inst Monogr 3:277–292PubMed Zubrod CG, Ipsen J, Frei E, Lasagna LC, Lipsett MB, Gehan E, Escher GC (1960) Newer techniques and some problems in cooperative group studies. Natl Cancer Inst Monogr 3:277–292PubMed
19.
go back to reference Oken MM, Creech RH, Tormey DC, Horton J, Davis TE, McFadden ET, Carbone PP (1982) Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 5:649–655PubMedCrossRef Oken MM, Creech RH, Tormey DC, Horton J, Davis TE, McFadden ET, Carbone PP (1982) Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 5:649–655PubMedCrossRef
20.
go back to reference Buccheri G, Ferrigno D (1994) Prognostic factors in lung cancer: tables and comments. Eur Respir J 7:1350–1364PubMedCrossRef Buccheri G, Ferrigno D (1994) Prognostic factors in lung cancer: tables and comments. Eur Respir J 7:1350–1364PubMedCrossRef
21.
go back to reference Buccheri G, Ferrigno D, Tamburini M (1996) Karnofsky and ECOG performance status scoring in lung cancer: a prospective, longitudinal study of 536 patients from a single institution. Eur J Cancer 32A:1135–1141PubMedCrossRef Buccheri G, Ferrigno D, Tamburini M (1996) Karnofsky and ECOG performance status scoring in lung cancer: a prospective, longitudinal study of 536 patients from a single institution. Eur J Cancer 32A:1135–1141PubMedCrossRef
22.
go back to reference Sørensen JB, Klee M, Palshof T, Hansen HH (1993). Performance status assessment in cancer patients. An inter-observer variability study. Br J Cancer. 67(4):773–5 Sørensen JB, Klee M, Palshof T, Hansen HH (1993). Performance status assessment in cancer patients. An inter-observer variability study. Br J Cancer. 67(4):773–5
23.
go back to reference Amer MH, Al-Sarraf M, Vaitkevicius VK (1979) Factors that affect response to chemotherapy and survival of patients with advanced head and neck cancer. Cancer 43:2202–2206PubMedCrossRef Amer MH, Al-Sarraf M, Vaitkevicius VK (1979) Factors that affect response to chemotherapy and survival of patients with advanced head and neck cancer. Cancer 43:2202–2206PubMedCrossRef
24.
go back to reference Capuano G, Gentile PC, Bianciardi F, Tosti M, Palladino A, Di PM (2010) Prevalence and influence of malnutrition on quality of life and performance status in patients with locally advanced head and neck cancer before treatment. Support Care Cancer 18:433–437PubMedCrossRef Capuano G, Gentile PC, Bianciardi F, Tosti M, Palladino A, Di PM (2010) Prevalence and influence of malnutrition on quality of life and performance status in patients with locally advanced head and neck cancer before treatment. Support Care Cancer 18:433–437PubMedCrossRef
25.
go back to reference Uygun K, Bilici A, Karagol H, Caloglu M, Cicin I, Aksu G, Fayda M, Uzunoglu S (2009) The comparison of weekly and three-weekly cisplatin chemotherapy concurrent with radiotherapy in patients with previously untreated inoperable non-metastatic squamous cell carcinoma of the head and neck. Cancer Chemother Pharmacol 64:601–605PubMedCrossRef Uygun K, Bilici A, Karagol H, Caloglu M, Cicin I, Aksu G, Fayda M, Uzunoglu S (2009) The comparison of weekly and three-weekly cisplatin chemotherapy concurrent with radiotherapy in patients with previously untreated inoperable non-metastatic squamous cell carcinoma of the head and neck. Cancer Chemother Pharmacol 64:601–605PubMedCrossRef
26.
go back to reference Shanmugaratnam K, Sobin LH (1993) The World Health Organization histological classification of tumours of the upper respiratory tract and ear. A commentary on the second edition. Cancer 71:2689–2697PubMedCrossRef Shanmugaratnam K, Sobin LH (1993) The World Health Organization histological classification of tumours of the upper respiratory tract and ear. A commentary on the second edition. Cancer 71:2689–2697PubMedCrossRef
27.
28.
go back to reference Roila F, Lupattelli M, Sassi M, Basurto C, Bracarda S, Picciafuoco M, Boschetti E, Milella G, Ballatori E, Tonato M (1991) Intra and interobserver variability in cancer patients' performance status assessed according to Karnofsky and ECOG scales. Ann Oncol 2:437–439PubMed Roila F, Lupattelli M, Sassi M, Basurto C, Bracarda S, Picciafuoco M, Boschetti E, Milella G, Ballatori E, Tonato M (1991) Intra and interobserver variability in cancer patients' performance status assessed according to Karnofsky and ECOG scales. Ann Oncol 2:437–439PubMed
29.
go back to reference Kaplan EL, Meyer P (1958) Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457–481CrossRef Kaplan EL, Meyer P (1958) Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457–481CrossRef
30.
go back to reference Mantel N (1966) Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 50:163–170PubMed Mantel N (1966) Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 50:163–170PubMed
31.
go back to reference Cox DR (1972) Regression models and life tables. J Roy Statist Soc 34:187–220 Cox DR (1972) Regression models and life tables. J Roy Statist Soc 34:187–220
32.
go back to reference Tromp DM, Brouha XD, Hordijk GJ, Winnubst JA, de Leeuw JR (2005) Patient factors associated with delay in primary care among patients with head and neck carcinoma: a case-series analysis. Fam Pract 22:554–559PubMedCrossRef Tromp DM, Brouha XD, Hordijk GJ, Winnubst JA, de Leeuw JR (2005) Patient factors associated with delay in primary care among patients with head and neck carcinoma: a case-series analysis. Fam Pract 22:554–559PubMedCrossRef
33.
go back to reference Kowalski LP, Franco EL, Torloni H, Fava AS, de Andrade Sobrinho J, Ramos G, Oliveira BV, Curado MP (1994) Lateness of diagnosis of oral and oropharyngeal carcinoma: factors related to the tumour, the patient and health professionals. Eur J Cancer B Oral Oncol 30B(3):167–173PubMedCrossRef Kowalski LP, Franco EL, Torloni H, Fava AS, de Andrade Sobrinho J, Ramos G, Oliveira BV, Curado MP (1994) Lateness of diagnosis of oral and oropharyngeal carcinoma: factors related to the tumour, the patient and health professionals. Eur J Cancer B Oral Oncol 30B(3):167–173PubMedCrossRef
34.
go back to reference Logemann JA, Rademaker AW, Pauloski BR, Lazarus CL, Mittal BB, Brockstein B, MacCracken E, Haraf DJ, Vokes EE, Newman LA, Liu D (2006) Site of disease and treatment protocol as correlates of swallowing function in patients with head and neck cancer treated with chemoradiation. Head Neck 28:64–73PubMedCrossRef Logemann JA, Rademaker AW, Pauloski BR, Lazarus CL, Mittal BB, Brockstein B, MacCracken E, Haraf DJ, Vokes EE, Newman LA, Liu D (2006) Site of disease and treatment protocol as correlates of swallowing function in patients with head and neck cancer treated with chemoradiation. Head Neck 28:64–73PubMedCrossRef
35.
go back to reference Manikantan K, Sayed SI, Syrigos KN, Rhys-Evans P, Nutting CM, Harrington KJ, Kazi R (2009) Challenges for the future modifications of the TNM staging system for head and neck cancer: case for a new computational model? Cancer Treat Rev 35:639–644PubMedCrossRef Manikantan K, Sayed SI, Syrigos KN, Rhys-Evans P, Nutting CM, Harrington KJ, Kazi R (2009) Challenges for the future modifications of the TNM staging system for head and neck cancer: case for a new computational model? Cancer Treat Rev 35:639–644PubMedCrossRef
36.
go back to reference Ryu CW, Kim JK, Kim SJ, Lee JH, Kim JH, Ha HI, Suh DC (2009) Head and neck vascular lesions: characterization of the flow pattern by the use of three-phase CT. Korean J Radiol 10:323–332PubMedCrossRef Ryu CW, Kim JK, Kim SJ, Lee JH, Kim JH, Ha HI, Suh DC (2009) Head and neck vascular lesions: characterization of the flow pattern by the use of three-phase CT. Korean J Radiol 10:323–332PubMedCrossRef
37.
go back to reference Stenson KM, MacCracken E, List M, Haraf DJ, Brockstein B, Weichselbaum R, Vokes EE (2000). Swallowing function in patients with head and neck cancer prior to treatment. Arch Otolaryngol Head Neck Surg 26:371–7 Stenson KM, MacCracken E, List M, Haraf DJ, Brockstein B, Weichselbaum R, Vokes EE (2000). Swallowing function in patients with head and neck cancer prior to treatment. Arch Otolaryngol Head Neck Surg 26:371–7
38.
go back to reference Ekberg O, Hamdy S, Woisard V, Wuttge-Hannig A, Ortega P (2002) Social and psychological burden of dysphagia: its impact on diagnosis and treatment. Dysphagia 17:139–146PubMedCrossRef Ekberg O, Hamdy S, Woisard V, Wuttge-Hannig A, Ortega P (2002) Social and psychological burden of dysphagia: its impact on diagnosis and treatment. Dysphagia 17:139–146PubMedCrossRef
39.
go back to reference Nguyen NP, Frank C, Moltz CC, Karlsson U, Nguyen PD, Ward HW, Vos P, Smith HJ, Huang S, Nguyen LM, Lemanski C, Ludin A, Sallah S (2009) Analysis of factors influencing dysphagia severity following treatment of head and neck cancer. Anticancer Res 29:3299–3304PubMed Nguyen NP, Frank C, Moltz CC, Karlsson U, Nguyen PD, Ward HW, Vos P, Smith HJ, Huang S, Nguyen LM, Lemanski C, Ludin A, Sallah S (2009) Analysis of factors influencing dysphagia severity following treatment of head and neck cancer. Anticancer Res 29:3299–3304PubMed
40.
go back to reference Pauloski BR, Rademaker AW, Logemann JA, Lazarus CL, Newman L, Hamner A, MacCracken E, Gaziano J, Stachowiak L (2002) Swallow function and perception of dysphagia in patients with head and neck cancer. Head Neck 24:555–565PubMedCrossRef Pauloski BR, Rademaker AW, Logemann JA, Lazarus CL, Newman L, Hamner A, MacCracken E, Gaziano J, Stachowiak L (2002) Swallow function and perception of dysphagia in patients with head and neck cancer. Head Neck 24:555–565PubMedCrossRef
41.
go back to reference Ravasco P, Monteiro-Grillo I, Vidal PM, Camilo ME (2003) Nutritional deterioration in cancer: the role of disease and diet. Clin Oncol (R Coll Radiol) 15:443–450CrossRef Ravasco P, Monteiro-Grillo I, Vidal PM, Camilo ME (2003) Nutritional deterioration in cancer: the role of disease and diet. Clin Oncol (R Coll Radiol) 15:443–450CrossRef
42.
go back to reference Ravasco P, Monteiro-Grillo I, Vidal PM, Camilo ME (2004) Cancer: disease and nutrition are key determinants of patients' quality of life. Support Care Cancer 12:246–252PubMedCrossRef Ravasco P, Monteiro-Grillo I, Vidal PM, Camilo ME (2004) Cancer: disease and nutrition are key determinants of patients' quality of life. Support Care Cancer 12:246–252PubMedCrossRef
43.
go back to reference Kowalski LP, Carvalho AL, Martins Priante AV, Magrin J (2005) Predictive factors for distant metastasis from oral and oropharyngeal squamous cell carcinoma. Oral Oncol 41:534–541PubMedCrossRef Kowalski LP, Carvalho AL, Martins Priante AV, Magrin J (2005) Predictive factors for distant metastasis from oral and oropharyngeal squamous cell carcinoma. Oral Oncol 41:534–541PubMedCrossRef
44.
go back to reference Wunsch-Filho V (2002) The epidemiology of oral and pharynx cancer in Brazil. Oral Oncol 38:737–746PubMedCrossRef Wunsch-Filho V (2002) The epidemiology of oral and pharynx cancer in Brazil. Oral Oncol 38:737–746PubMedCrossRef
Metadata
Title
Analysis of ECOG performance status in head and neck squamous cell carcinoma patients: association with sociodemographical and clinical factors, and overall survival
Authors
Gefter Thiago Batista Corrêa
Gabriela Alencar Bandeira
Bruna Gonçalves Cavalcanti
Francis Balduíno Guimarães Santos
João Felício Rodrigues Neto
André Luiz Sena Guimarães
Desirée Sant’Ana Haikal
Alfredo Maurício Batista De Paula
Publication date
01-11-2012
Publisher
Springer-Verlag
Published in
Supportive Care in Cancer / Issue 11/2012
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-012-1386-y

Other articles of this Issue 11/2012

Supportive Care in Cancer 11/2012 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine